Letter by Escobar et al Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF"

Carlos Escobar¹, Vivencio Barrios¹, Jose Luis Gorriz¹

Affiliations

Affiliation

¹ From Cardiology Department, Hospital Universitario La Paz, Madrid, Spain (C.E.); Cardiology Department, Hospital Ramon y Cajal, Department of Medicine, University of Alcala de Henares, Madrid, Spain (V.B.); and Nephrology Department, Hospital Doctor Peset, Department of Medicine, University of Valencia, Spain (J.L.G.).

PMID: 27895027
DOI: 10.1161/CIRCULATIONAHA.116.024514

Comment

Letter by Escobar et al Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF"

Carlos Escobar et al. Circulation. 2016.

. 2016 Nov 29;134(22):e530-e531.

doi: 10.1161/CIRCULATIONAHA.116.024514.

Authors

Carlos Escobar¹, Vivencio Barrios¹, Jose Luis Gorriz¹

Affiliation

¹ From Cardiology Department, Hospital Universitario La Paz, Madrid, Spain (C.E.); Cardiology Department, Hospital Ramon y Cajal, Department of Medicine, University of Alcala de Henares, Madrid, Spain (V.B.); and Nephrology Department, Hospital Doctor Peset, Department of Medicine, University of Valencia, Spain (J.L.G.).

PMID: 27895027
DOI: 10.1161/CIRCULATIONAHA.116.024514

No abstract available

PubMed Disclaimer

Comment in

Response by Fordyce et al to Letter Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF".
Fordyce CB, Piccini JP, Patel MR. Fordyce CB, et al. Circulation. 2016 Nov 29;134(22):e532-e533. doi: 10.1161/CIRCULATIONAHA.116.025258. Circulation. 2016. PMID: 27895028 No abstract available.

Comment on

On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
Fordyce CB, Hellkamp AS, Lokhnygina Y, Lindner SM, Piccini JP, Becker RC, Berkowitz SD, Breithardt G, Fox KA, Mahaffey KW, Nessel CC, Singer DE, Patel MR; ROCKET AF Steering Committee and Investigators. Fordyce CB, et al. Circulation. 2016 Jul 5;134(1):37-47. doi: 10.1161/CIRCULATIONAHA.116.021890. Circulation. 2016. PMID: 27358435 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Letter by Escobar et al Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF"

Affiliation

Letter by Escobar et al Regarding Article, "On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF"

Authors

Affiliation

Comment in

Comment on

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical